Noticias de ANIP_US

Noticias del mercado

Últimas noticias sobre ANIP_US — 252 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ANIP_US ✕ 252 resultados
13/05/2026 ANIP_US — Stock Titan ES ← EN
El director de ANI Pharmaceuticals (NASDAQ:ANIP) vende 13.973 acciones en operaciones de mercado abierto

ANI Pharmaceuticals (NASDAQ: ANIP) director sells 13,973 shares in open-market trades

13/05/2026 ANIP_US — Investing.com ES ← EN
El director de ANI Pharmaceuticals, Walsh, vende acciones por valor de 1,13 millones de dólares

ANI Pharmaceuticals director Walsh sells $1.13m in stock

13/05/2026 ANIP_US — GuruFocus ES ← EN
Venta privilegiada: Meredith Cook vende 500 acciones de ANI Pharmaceuticals Inc (ANIP)

Insider Sell: Meredith Cook Sells 500 Shares of ANI Pharmaceuticals Inc (ANIP)

13/05/2026 ANIP_US — Stock Titan ES ← EN
[Formulario 4] Actividad de uso de información privilegiada de ANI PHARMACEUTICALS INC

[Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity

13/05/2026 ANIP_US — Stock Titan ES ← EN
El director ejecutivo de ANI Pharmaceuticals (ANIP) vende 55.000 acciones a 77,57 dólares de media

ANI Pharmaceuticals (ANIP) CEO sells 55,000 shares at $77.57 average

13/05/2026 ANIP_US — Stock Titan ES ← EN
Vicepresidente senior de ANI Pharmaceuticals (ANIP) vende 2.772 acciones ordinarias

ANI Pharmaceuticals (ANIP) SVP sells 2,772 common shares

13/05/2026 ANIP_US — Stock Titan ES ← EN
El jefe legal de ANI Pharmaceuticals (ANIP) vende 500 acciones bajo el plan 10b5-1

ANI Pharmaceuticals (ANIP) legal chief sells 500 shares under 10b5-1 plan

13/05/2026 ANIP_US — Stock Titan
[144] ANI PHARMACEUTICALS INC SEC Filing
13/05/2026 ANIP_US — Minichart
ANI Pharmaceuticals Announces May 2026 Investor Presentation Highlighting Generics Growth and U.S. Manufacturing Footprint
13/05/2026 ANIP_US — TipRanks
ANI Pharmaceuticals Updates Investor Presentation, Highlights Non-GAAP Metrics
13/05/2026 ANIP_US — TradingView
ANI Pharmaceuticals projects ~$1.1B 2026 revenue; raises guidance, $100M buyback authorized
13/05/2026 ANIP_US — Stock Titan
ANI Pharmaceuticals (NASDAQ: ANIP) targets ~$1.1B in 2026 revenue
13/05/2026 ANIP_US — MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Vanguard Group Inc.
11/05/2026 ANIP_US — Stock Titan
[144] ANI PHARMACEUTICALS INC SEC Filing
11/05/2026 ANIP_US — Stock Titan
Patrick Walsh plans sale of 3,973 ANIP shares (NASDAQ: ANIP)
11/05/2026 ANIP_US — Yahoo Finance
Zacks.com featured highlights include ANI, Cummins and Seadrill

ANI, Cummins y Seadrill se destacan en este artículo de Pantalla de la semana.

11/05/2026 ANIP_US — MSN
ANI Pharmaceuticals raises 2026 revenue outlook to $1.08B-$1.14B while launching $100M share repurchase program
11/05/2026 ANIP_US — MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Recommendation of "Moderate Buy" by Brokerages

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Obtenga informe gratuito) obtuvo una recomendación consensuada de "Compra moderada" de las ocho firmas de calificación que actualmente cubren la compañía, informa MarketBeat Ratings. Dos analistas han calificado la acción con una calificación de mantener, cinco han emitido una calificación de compra y

10/05/2026 ANIP_US — GuruFocus
Perkins Discovery Fund's ANI Pharmaceuticals Inc(ANIP) Holding History
09/05/2026 ANIP_US — Investing.com
ANI Pharmaceuticals Inc (ANIP) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus

Página 1 de 13

keyboard_arrow_up